Statements (57)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:drug
|
gptkbp:bfsLayer |
5
|
gptkbp:bfsParent |
gptkb:Allergan's_aesthetics_portfolio
gptkb:Allergan_Aesthetics |
gptkbp:appointed_by |
injections
|
gptkbp:approves |
gptkb:2015
gptkb:FDA |
gptkbp:brand |
gptkb:Kybella
|
gptkbp:capacity |
0.2 m L to 1.2 m L per session
|
gptkbp:clinical_trial |
Phase III
cosmetic procedure demonstrated efficacy demonstrated safety |
gptkbp:diet |
not a weight loss treatment
|
gptkbp:duration |
30 to 60 minutes
permanent fat reduction |
gptkbp:education |
informed consent required
|
gptkbp:events |
monitoring for side effects
|
gptkbp:feedback |
high satisfaction rates
|
gptkbp:frequency |
every 4 to 6 weeks
|
gptkbp:healthcare |
April 2015
|
https://www.w3.org/2000/01/rdf-schema#label |
Kybella
|
gptkbp:ingredients |
deoxycholic acid
|
gptkbp:is_used_for |
reducing submental fat
|
gptkbp:is_used_in |
gptkb:Person
people with bleeding disorders people with allergies to deoxycholic acid people with severe obesity people with skin conditions at injection sites |
gptkbp:manufacturer |
gptkb:Allergan
|
gptkbp:max_takeoff_weight |
up to 6 treatments
|
gptkbp:price |
varies by provider
|
gptkbp:result |
2 to 4 weeks
|
gptkbp:side_effect |
headache
bruising swelling redness difficulty swallowing numbness pain at injection site nerve injury |
gptkbp:suitable_for |
pregnant women
people with certain medical conditions people with infections at injection sites |
gptkbp:target_audience |
adults
|
gptkbp:treatment |
gptkb:Cool_Sculpting
minimal downtime liposuction double chin boosted self-esteem enhanced facial contour improved jawline appearance multiple sessions required reduced fat under chin |
gptkbp:website |
subcutaneous injection
multiple injections per session submental area |